SIRT6 Inhibitor, OSS_128167 Restricts Hepatitis B Virus Transcription and Replication Through Targeting Transcription Factor Peroxisome Proliferator-Activated Receptors α

Hepatitis B virus (HBV) is a major public health threat and anti-HBV drugs are limited to nucleos(t)ide analogs (NAs) and pegylated interferon alpha (Peg-IFNα). Toward identifying an effective compound for HBV treatment is important to suppress and eradicate HBV. In this study, we explored the anti-...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Hui, Cheng, Sheng-Tao, Ren, Ji-Hua, Ren, Fang, Yu, Hai-Bo, Wang, Qing, Huang, Ai-Long, Chen, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823301/
https://www.ncbi.nlm.nih.gov/pubmed/31708789
http://dx.doi.org/10.3389/fphar.2019.01270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823301/
https://www.ncbi.nlm.nih.gov/pubmed/31708789
http://dx.doi.org/10.3389/fphar.2019.01270

Ejemplares similares